Destination

2025-04-01

Here's how much Ozempic and similar drugs have soared in popularity since 2018

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.

Read more...

[...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination

2025-02-28

Engadget Podcast: iPhone 16e review and Amazon's AI-powered Alexa+

The keyword for the iPhone 16e seems to be "compromise." In this episode, Devindra chats with Cherlynn about her iPhone 16e review and try to figure out who this phone is actually for. Also, [...]

Match Score: 81.23

thenextweb

2025-01-10

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 76.66

Destination

2025-05-30

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 66.80

Destination

2025-05-22

Google's most powerful AI tools aren't for us

At I/O 2025, nothing Google showed off felt new. Instead, we got a retread of the company's familiar obsession with its own AI prowess. For the better part of two hours, Google spent playing up p [...]

Match Score: 58.99

Destination

2025-02-27

iPhone 16e review: What's your acceptable compromise?

I’ve been traveling through time this week. Reviewing the iPhone 16e feels at once like I’m visiting my younger self and also forced to live in olden times, especially since I’ve been using an i [...]

Match Score: 49.77

Destination

2025-03-07

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]

Match Score: 48.73

Destination

2025-08-13

Norton VPN review: A VPN that fails to meet Norton's standards

One thing I need to make clear right from the start: this is a review of Norton VPN (formerly Norton Secure VPN, and briefly Norton Ultra VPN) as a standalone app, not of the VPN feature in the Norton [...]

Match Score: 48.13

cnet

2025-10-06

Costco Is Now Selling Ozempic and Other GLP-1 Drugs. These Are the Benefits and Risks You Need to Know

At its pharmacy, Costco now offers Ozempic and Wegovy at huge discounts, but are these GLP-1 drugs right for you? [...]

Match Score: 46.93

Destination

2025-03-31

Nintendo Switch 2: Everything we know about pre-order plans, specs, pricing, games and more

The Nintendo Switch 2 will arrive in 2025, over eight years after its predecessor. Nintendo officially revealed the successor to its best-selling home console in a brief trailer on January 16. Now it& [...]

Match Score: 46.28